patritumab
daiichi sankyo
['bcsm', 'patritumab', 'mbc']
patritumab dxd - her3 adc: 182 mbc her3+, any subtype, 2-6 prior tx. orr 22-42 depending on subtype (+her2), dor 6-8 m, ?role of her3 as a predictive marker #bcsm #asco22 
Breast medical oncologist @TuftsMedicalCtr | Tweets are my own | ???? ????